Does Azithromycin and Cetirizine Combination Given for Upper Respiratory Tract Infections has any Significant Effect on QTc?
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 9
Abstract
Introduction: Azithromycin usage in patients with baseline cardiovascular risk is associated with increased risk of cardiovascular mortality, following which Food and Drug Administration (FDA) issued a black box warning regarding safety of azithromycin in patients with cardiovascular morbidity particularly with prolonged QTc. Cetirizine is a second generation anti histaminic and is found to be commonly used for Upper Respiratory Tract Infections (URIs) along with azithromycin on outpatient basis. Whether, usage of these two drugs in combination confers a similar risk, is unknown. Aim: To assess the effect on QTc among patients treated with azithromycin and cetirizine combination for upper respiratory tract infection. Materials and Methods: We conducted a prospective longitudinal study from August 2014 to July 2016. The study was done on 45 patients above 18 years of age without any cardiovascular morbidity in whom azithromycin and cetirizine were prescribed for upper respiratory tract infections. We compared the QTc on day 1 and day 4. Data was analysed using Student’s paired t-test. Results: During three days of azithromycin and cetirizine for upper respiratory tract infections, we observed that on day 4 there was significant increase in QTc in 43 patients (95.6%) as compared with the QTc on day 1. We also observed that in 8 (17.8%) out of 45 patients, QTc on day 4 crossed the upper limit of normal {430 milliseconds (ms)}, but this was not statistically significant. However, analysing these eight patients, we obtained the baseline QTc of 377.50 ms above which if prescribed, this combination of drugs have a chance of prolonging the QTc above 430 ms with a sensitivity of 87.5% and specificity of 40.5%. Conclusion: During three days treatment with azithromycin and cetirizine, there was significant change in QTc between day 1 and day 4. Patients with baseline QTc greater than 377.5 ms were at risk of QTc prolongation above 430 ms on day 4.
Authors and Affiliations
Kishor Kumar Rajasekaran, Jayakumar Jeganathan, Pavan Manibettu Raghuram
Keywords
Related Articles
- EP ID EP362981
- DOI 10.7860/JCDR/2017/26525.10573
- Views 45
- Downloads 0
FNAC is a Boon for Salivary Gland Lesions: A Routine Diagnostic Experience among Rural Population
ABSTRACT Introduction: Salivary gland comprises of major and minor salivary glands. FNAC is a diagnostic method based on morphologic findings of individuals and group of cells. FNAC is accepted as an excellent investigat...
Nasal NK/T Cell Lymphoma Presenting with Perforation of Palate: A Case Report and Review of Literature
Nasal Natural Killer (NK)/T cell lymphoma, commonly mentioned in the literature as Lethal Midline Granuloma (LMG) is an unusual pathology of the oro-maxillo-facial region characterized by aggressive and progressive destr...
Dosimetric Comparison between Two Different Intensity Modulated Radiation Therapy and 3D-Conformal Radiation Therapy Planning Techniques for Carcinoma of Breast Following Conservative Surgery
Abstract Introduction: The anatomy of the chest wall is curved which makes it quite complicated to plan radiation therapy for breast cancer. There are different techniques for delivering external beam radiation therapy....
Prognostic Value of Epidermal Growth Factor Receptor in Colorectal Carcinoma
ABSTRACT Introduction: Colorectal carcinoma is a common malignancy with a worldwide distribution. AJCC tumour staging is the single most important prognostic indicator which is also used for selecting cases for postopera...
Challenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing
Letter to Editor